China

Latest News and Resources

Chart

A Category 5 Super Typhoon Is Tracking Toward 630 China and Taiwan Pharma Manufacturing Sites

8 July 2026

Policy Briefing

Congress Proposes Federal Oversight for US-China Drug Licensing Deals

4 June 2026

Content

China Biopharma Out-Licensing Surges to Record $137.7B in 2025, 2026 on Pace to Break It Again

20 February 2026

Dr. Reza Oliyai, President and CEO of Oliyai Consulting Corporation

Podcast

How Biotechs Can De-Risk External Manufacturing, Navigate Geopolitical Challenges, and Plan for Capacity Constraints – Dr. Reza Oliyai

9 February 2026

Content

AstraZeneca Plans $15B China Investment Through 2030

29 January 2026

Expert Insight

China’s Biotech Ascent Reshapes Global Pharma Strategy, Dominates JPM26 Discussions

19 January 2026

Manufacturing

Trend Briefing: “China-Proofing” the Pharma Supply Chain

3 September 2023

Podcast

How Cognition Therapeutics Cut Cost of Goods by 85% Through Smarter CMC Strategy

9 July 2020

Expert Insight

Radioligand Therapy: How China Is Shaping the Future of CDMO Infrastructure

27 March 2020